芯源微(688037.SH):公司生產的前道物理清洗機、後道濕法類設備已成為國內主流產品
格隆匯4月25日丨有投資者通過上證E互動向芯源微(688037.SH) 提問,"公司在清洗設備上技術實力如何?從營收上看沒能進入國內前三,後續有什麼計劃嗎?要麼不做,要做就起碼做到前三吧,就象貴司塗膠顯影設備一樣,處於領頭羊地位 "。
芯源微(688037.SH)回覆稱,"公司已掌握清洗領域多項核心技術,在晶圓正反面顆粒清洗、化學藥品精確供給及回收、內部微環境精確控制等技術方面已達到國際先進水平。近年來公司生產的前道物理清洗機、後道濕法類設備已成為國內主流產品,公司後續也將推出化學清洗機產品,進一步豐富產品線。感謝您提供的寶貴建議! "
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.